Mixonix changes accounting firm
Misonix (Farmigdale, New York), a developer of ultrasonic medical device systems to treat cancer and other conditions, said that its audit committee has retained Grant Thornton as its independent public accounting firm, replacing Ernst & Young, the company's auditor since 1993.
The company said the change was not related to any disagreement with Ernst & Young. Misonix said it sought to engage a firm “with a global reach that is focused on serving middle-market public companies and that has relevant medical technology experience.“
Misonix, which will be served by Grant Thornton's Melville, New York, office, manufactures medical, scientific and industrial ultrasonic and air pollution systems.
FCC provides implant waiver to DexCom
Glucose monitoring systems developer DexCom (San Diego) reported that the Federal Communications Commission (FCC) has granted its request for a waiver from certain Medical Implant Communications Service (MICS) rules concerning radio frequency transmissions of its short-term and long-term continuous glucose monitoring systems. The waiver provides clearance for the DexCom continuous glucose monitoring systems to wirelessly transmit data to patients in the MICS band.
DexCom previously cited the need to obtain this waiver in its filings with the Securities and Exchange Commission.
According to DexCom, the FCC based its waiver on “the significant medical value of these devices as presently constituted for current diabetic patients . . . The substantial public interest in making a blood glucose monitoring system available is uncontested.“